Update To Bidding Process
In continuation to our letter(s) ref. no. FHL/SEC/STEX/RR/2018-19 dated May 29, 2018 and June 11, 2018, the date for submission of the Binding Bids as mentioned under Paragraph 4 of the Transaction Process Letter dated May 29, 2018, stands revised to Thursday, the June 28, 2018. Rest of the details with respect to the timings and submission remain the same. You are kindly requested to take the same on record. Board Meeting-Outcome of Board Meeting
The internal investigation conducted by Luthra & Luthra Law Offices, as initiated by the Audit and Risk Management Committee, has been completed and their report was made available on June 8, 2018. The same was duly placed before the Audit and Risk Management Committee and the Board at their meetings held today. The Report has been shared with the statutory auditors and is being submitted to SEBI and SFIO forthwith.... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for York Asian Opport Inv Mast FD LP and York Multi Strategy Master Fund LP Fortis due diligence reveals unpaid vendors' bills of Rs 450 crore: Report
Fortis Healthcare's due diligence by suitors has reportedly unearthed unpaid vendors' bills of Rs 450 crore and a penalty on its subsidiary Fortis Escorts Heart Institute that's to the tune of Rs 503 crore. Regulation 30 Update- EWS Order
This is in continuation to the letters dated June 10, August 2, 2016 and May 29, 2018, whereby the Company had informed that one of our subsidiaries viz. EHIRCL had received an order dated 28.5.2018 from the Office of the Special Committee directing it to deposit an amount of Rs. 503, 36, 52, 824/- in the account of the Delhi Government, in favour of Director General of Health Services, within month of receiving the said order.... Status Update On Fresh Bidding Process
This is with reference to our letter ref no. FHL/SEC/STEX/RR/2018-19 dated May 29, 2018 to the stock exchanges regarding the fresh bidding process. In the said context, the Company has received interest from various interested parties on May 31, 2018 as per the timelines specified in the Invitation for Transaction Participation. The Board of the Company has now decided to include the following four parties in the Process and has initiated various... Regulation 30 Update- Appointment Of Chairman
This is to inform that the Board of Directors today, by circulation, appointed Mr. Ravi Rajagopal, Non-Executive Independent Director as the Chairman of the Board with immediate effect. The same may kindly be read in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records please. Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Fortis Healthcare International Limited, a wholly owned subsidiary of Fortis Healthcare Limited- hereinafter referred to as 'Company') has on May 30, 2018 sold off 18.2 million units of RHT Health Trust, an associate of the Company. The detailed disclosure as required under Regulation 30 is attached herewith. Fortis defers announcement of Q4 results
Fortis Healthcare on Wednesday said the board meeting scheduled to consider its financial results for the fourth quarter and financial year ended Marc